Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib

TY - JOUR

T1 - Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib

AU - Zhou, A.

AU - Knoche, E. M.

AU - Engle, E. K.

AU - Fisher, D. A.C.

AU - Oh, S. T.

N1 - Funding Information: This work was supported by NIH grants K08HL106576 (Oh), K12HL087107 (Oh) and T32HL007088 (Engle, Fisher). Technical support was provided by the Alvin J. Siteman Cancer Center Tissue Procurement and Flow Cytometry Cores, which are supported by NCI Cancer Center Support Grant P30CA91842. We thank D. Moore for assistance with tissue banking, and L. He, G. Rippberger and M. Fulbright for assistance with JAK2 and BCR-ABL genotyping experiments.

PY - 2015/10/2

Y1 - 2015/10/2

UR - https://www.scopus.com/pages/publications/84943187510

U2 - 10.1038/bcj.2015.77

DO - 10.1038/bcj.2015.77

M3 - Article

C2 - 26430722

AN - SCOPUS:84943187510

SN - 2044-5385

VL - 5

SP - e351

JO - Blood cancer journal

JF - Blood cancer journal

ER -